Armed car-macrophage compositions and methods for therapy of glioblastoma multiforme

Abstract

A nanoparticle for treating glioblastoma multiforme (GBM) in which the nanoparticle includes a lipid phase and a core that contains one or more nucleic acids encoding a chimeric antigen receptor (CAR), a T-cell engager (TCE), and / or a therapeutic gene. The CAR and the TCE each binding specifically to a GBM tumor-associated antigen and the nanoparticle selectively delivers the one or more nucleic acids to M2 macrophages in vitro and in vivo. Also provided is a therapeutic composition that contains a plurality of the nanoparticle described above and a pharmaceutically acceptable excipient. Further provided are methods for converting GBM tumor-resident M2 macrophages into M1 macrophages, and for treating GBM.

Images